Literature DB >> 9675156

Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture.

H Ikeda1, Y Yatomi, M Yanase, H Satoh, A Nishihara, M Kawabata, K Fujiwara.   

Abstract

Lysophosphatidic acid (LPA) is a growth factor-like mediator for fibroblasts or smooth muscle cells produced and released by activated platelets. Platelet activation occurs with hepatic necrosis and subsequent liver regeneration and fibrosis. In the fibrosis, hepatic stellate cells proliferate with phenotypic transformation to myofibroblasts. Thus, effects of LPA on proliferation of hepatocytes and stellate cells were investigated. In cultured rat stellate cells, LPA increased DNA synthesis with enhanced MAP kinase activity. Pertussis toxin (PTX) attenuated this mitogenic action. In contrast, LPA decreased DNA synthesis by cultured rat hepatocytes induced by hepatocyte growth factor (HGF) or epidermal growth factor (EGF) without affecting protein synthesis. Enhanced MAP kinase activity by HGF or EGF was not changed by LPA. This anti-mitogenic action was attenuated by PTX. TGFbeta level in the medium was less than the level effective for inhibiting the DNA synthesis in the presence of LPA. Our results suggest that LPA might affect proliferation of hepatocytes and stellate cells in liver diseases complicating platelet activation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675156     DOI: 10.1006/bbrc.1998.8983

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

2.  Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy.

Authors:  Kerri A Simo; David J Niemeyer; Erin M Hanna; Jacob H Swet; Kyle J Thompson; David Sindram; David A Iannitti; Ashley L Eheim; Eugene Sokolov; Valentina Zuckerman; Iain H McKillop
Journal:  HPB (Oxford)       Date:  2013-09-24       Impact factor: 3.647

Review 3.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

4.  Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts.

Authors:  Zhaohong Yin; Laura D Carbone; Mari Gotoh; Arnold Postlethwaite; Alyssa L Bolen; Gabor J Tigyi; Kimiko Murakami-Murofushi; Mitchell A Watsky
Journal:  Rheumatology (Oxford)       Date:  2010-09-07       Impact factor: 7.580

Review 5.  Lysophosphatidic acid and renal fibrosis.

Authors:  Jean-Philippe Pradère; Julien Gonzalez; Julie Klein; Philippe Valet; Sandra Grès; David Salant; Jean-Loup Bascands; Jean-Sébastien Saulnier-Blache; Joost P Schanstra
Journal:  Biochim Biophys Acta       Date:  2008-04-11

Review 6.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

7.  Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice.

Authors:  Sherry Huang; Shu-Jen Chang; Miffy Yang; Justin Jin-Ching Chen; Walter H Chang
Journal:  Int J Nanomedicine       Date:  2011-07-01

8.  Lysophosphatidic acid alters the expression profiles of angiogenic factors, cytokines, and chemokines in mouse liver sinusoidal endothelial cells.

Authors:  Chia-Hung Chou; Shou-Lun Lai; Cheng-Maw Ho; Wen-Hsi Lin; Chiung-Nien Chen; Po-Huang Lee; Fu-Chuo Peng; Sung-Hsin Kuo; Szu-Yuan Wu; Hong-Shiee Lai
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Authors:  Thomas Pleli; Daniel Martin; Bernd Kronenberger; Friederike Brunner; Verena Köberle; Georgios Grammatikos; Harald Farnik; Yolanda Martinez; Fabian Finkelmeier; Sandra Labocha; Nerea Ferreirós; Stefan Zeuzem; Albrecht Piiper; Oliver Waidmann
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

Review 10.  Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments.

Authors:  Leonardo Baiocchi; Shannon Glaser; Heather Francis; Lindsey Kennedy; Eric Felli; Gianfranco Alpini; Jordi Gracia-Sancho
Journal:  Hepatol Commun       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.